348 related articles for article (PubMed ID: 19596875)
21. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
[TBL] [Abstract][Full Text] [Related]
22. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
[TBL] [Abstract][Full Text] [Related]
23. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Hahn-Ast C; Glasmacher A; Arns A; Mühling A; Orlopp K; Marklein G; Von Lilienfeld-Toal M
Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
[TBL] [Abstract][Full Text] [Related]
24. Linezolid versus vancomycin for skin and soft tissue infections.
Yue J; Dong BR; Yang M; Chen X; Wu T; Liu GJ
Cochrane Database Syst Rev; 2013 Jul; (7):CD008056. PubMed ID: 23846850
[TBL] [Abstract][Full Text] [Related]
25. Infective endocarditis and glycopeptides.
Pittet D; Harding I
J Infect; 1998 Sep; 37(2):127-35. PubMed ID: 9821086
[TBL] [Abstract][Full Text] [Related]
26. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R
Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
[TBL] [Abstract][Full Text] [Related]
28. The role of teicoplanin in the treatment of febrile neutropenia.
Menichetti F
J Chemother; 2000 Nov; 12 Suppl 5():34-9. PubMed ID: 11131962
[TBL] [Abstract][Full Text] [Related]
29. A review of the safety profile of teicoplanin.
Davey PG; Williams AH
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():69-73. PubMed ID: 1829079
[TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
31. Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
Hsiao SH; Chen HH; Chou CH; Lin WL; Liu Yeh PY; Wu TJ
J Clin Pharm Ther; 2010 Dec; 35(6):729-32. PubMed ID: 21054466
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.
Vardakas KZ; Mavros MN; Roussos N; Falagas ME
Mayo Clin Proc; 2012 Apr; 87(4):349-63. PubMed ID: 22469348
[TBL] [Abstract][Full Text] [Related]
33. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Chow AW; Jewesson PJ; Kureishi A; Phillips GL
Eur J Haematol Suppl; 1993; 54():18-24. PubMed ID: 8365461
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of tigecycline: a systematic review and meta-analysis.
Yahav D; Lador A; Paul M; Leibovici L
J Antimicrob Chemother; 2011 Sep; 66(9):1963-71. PubMed ID: 21685488
[TBL] [Abstract][Full Text] [Related]
35. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Rolston KV; Nguyen H; Amos G; Elting L; Fainstein V; Bodey GP
J Infect Dis; 1994 Feb; 169(2):350-5. PubMed ID: 8106768
[TBL] [Abstract][Full Text] [Related]
36. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
Sanche SE; Dust WN; Shevchuk YM
Clin Infect Dis; 2000 Sep; 31(3):824-5. PubMed ID: 11017842
[TBL] [Abstract][Full Text] [Related]
38. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
[TBL] [Abstract][Full Text] [Related]
39. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters.
Smith SR; Cheesbrough J; Spearing R; Davies JM
Antimicrob Agents Chemother; 1989 Aug; 33(8):1193-7. PubMed ID: 2529814
[TBL] [Abstract][Full Text] [Related]
40. Teicoplanin or vancomycin in the treatment of gram-positive infections?
Murphy S; Pinney RJ
J Clin Pharm Ther; 1995 Feb; 20(1):5-11. PubMed ID: 7775615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]